Core Insights - Cigna Group (CI) is a healthcare insurance provider with a market cap of $78 billion, offering various insurance products including life, accident, disability, supplemental, Medicare, and dental insurance [1] Performance Overview - CI shares have underperformed the broader market over the past year, gaining only 1.7% compared to the S&P 500 Index's nearly 14% increase [2] - In 2026, CI's stock rose 6.1%, outperforming the S&P 500's 1.3% rise on a year-to-date (YTD) basis [2] Comparison with Industry Peers - CI has outperformed the iShares U.S. Healthcare Providers ETF (IHF), which has declined about 12.8% over the past year, while CI's YTD returns exceed the ETF's 6% losses [3] Financial Results - On February 5, CI reported Q4 results with an adjusted EPS of $8.08, surpassing Wall Street expectations of $7.87, and adjusted revenue of $72.5 billion, exceeding forecasts of $69.9 billion [4] - For the current fiscal year ending in December, analysts expect CI's EPS to grow 1.5% to $30.28 on a diluted basis [5] Analyst Ratings - CI has a strong earnings surprise history, beating consensus estimates in the last four quarters, with a consensus rating of "Strong Buy" from 23 analysts [5] - RBC Capital analyst Ben Hendrix maintained a "Buy" rating on CI with a price target of $333, indicating a potential upside of 12.9% from current levels [6] - The mean price target of $330.95 suggests a 12.2% premium to CI's current price, while the highest target of $378 indicates an ambitious upside potential of 28.1% [6]